Blog Posts (30)
May 14, 2012
It has been implied by Carl Elliott and William Heisel that it has ever been claimed that “financial links between the Center for Practical Bioethics, AJOB and Purdue Pharma” exist and that “what reporters may find is that the center is tied up” with AJOB. …
October 4, 2011
When an investigational agent is being studied by pharma, is there an ethical responsibility to disclose the findings of that research, even if the agent is no longer being studied or being brought to market?…
August 11, 2011
When a reproductive oncologist in our clinical ethics certificate program did a presentation on drug shortages in oncology last month, I thought perhaps this was just a highly specialized problem.…
September 13, 2010
Watch to see the story of “The Life of a Professional Guinea Pig” courtesy of TIME.
Spencer, or as I would describe him a walking human pin cushion (shown below), tells his story of being a healthy volunteer for Phase I research.…
January 25, 2010
Hollywood has taken up orphan diseases before–remember “Lorenzo’s Oil”? And bioethics movies generally have been increasingly common, even just in the last year.…
November 2, 2009
Question: What is it worth to produce a blockbuster anti-wrinkle cream?
Hypothetical Answer from Cosmeceutical Company: A single skin biopsy of a 14-week old voluntarily aborted fetus from a minor with consent from her parents.…
July 21, 2009
Stem cells are, apparently, all the rage in the world of cosmetics. Slather them on your face to keep your face young and ageless or to simply make yourself more beautiful on your eyes, cheeks, or lips.…
May 18, 2009
According to Judith Graham at the Chicago Tribune’s Triage blog, Pfizer has created a new program to allow the unemployed–and thus uninsured–to keep access to their prescription drugs for one year.…
May 1, 2009
It’s a safe guess that somewhere at Merck today someone is going through the meeting minutes of the day that the hair-brained scheme for the Australasian Journal of Bone and Joint Medicine was launched, and that everyone who was in the room is now going to be fired.…
January 14, 2009
According to MSNBC, direct-to-consumer advertising for pharmaceuticals are cluttering the airwaves with offers to cure Americans of their bipolar disorder, irritable bowel disease, sleeplessness, acid reflux, high cholesterol and more.…
View More Blog Entries
July 28, 2014 4:30 pm
Drugs that have been investigated to increase so-called “good” cholesterol may not prevent deaths, heart attacks or strokes as many hoped, according to a new analysis.
March 25, 2014 2:53 pm
There is no cure for the condition, and therapies have proven difficult, as many have serious side effects. But now, relief may come in the form of a medical marijuana pill.
March 13, 2014 3:41 pm
Chimerix, a small and unprofitable biotechnology company, will make an experimental drug available to a young Virginia boy who is suffering from an infection he contracted while being treated for cancer.
July 24, 2012 9:15 am
In May, the Massachusetts Medical Society adopted policy supporting a change in the state’s gift ban so long as the modification conformed to guidelines from the ACCME and the American Medical Association. The AMA Code of Medical Ethics says it is OK for physicians to accept gifts worth $100 or less from industry so long as they benefit patients.
July 18, 2012 10:14 am
M.D. Anderson’s oversight of clinical trials of the drug AV-203 would violate ethics rules the institution created a decade ago after it failed to tell patients about the financial stake of its then-president, Dr. John Mendelsohn, in his drug Erbitux. “To me, this is a conflict of interest,” Dr. Leonard Zwelling, an M.D. Anderson professor who helped rewrite the ethics rules, said of the Aveo trial. “There is a system that got bypassed here.”
July 17, 2012 4:01 pm
It is commonly accepting that doping in sports should be strictly prohibited. But Oxford bio-ethicist Julian Savulescu disagrees. In an interview with SPIEGEL ONLINE on the eve of the London Olympics, he explains why bans are unrealistic and demands an open market for doping.
July 10, 2012 4:28 pm
Drugmakers that market powerful painkiller medications will be required to fund training programs to help U.S. doctors and other health professionals safely prescribe the drugs, which are blamed for thousands of fatal overdoses each year. The safety plan released by the Food and Drug Administration on Monday is designed to reduce misuse and abuse of long-acting opioid pain relievers, which include forms of morphine, methadone and oxycodone. The agency’s plan mainly involves educating doctors and patients about appropriate use of the drugs.
July 2, 2012 3:52 pm
The abuse, misuse and diversion of prescription drugs is a public health crisis. This is particularly apparent to those of us working in the emergency department, which is the largest ambulatory source of opioid medications. We all too frequently see individuals with untreated addiction issues, with life-threatening overdoses, and trying to obtain opioid medications for recreational use or to sell for profit.
June 6, 2012 12:04 pm
Doctors who treat cancer say a shortage of oncology drugs has eased, though shortages persist of some chemotherapy drugs that form the backbone of treatment for breast, colon, lung and some other cancers. Hospitals have been struggling with shortages of mostly older, generic drugs for cancer and other ailments for about two years.
May 29, 2012 1:01 pm
My case is individual, but it is not unique. I have known many depression patients, and their stories also tell of long, hard slogs through antidepressants that do not always work. They are not the lazy, over-consuming, morally hazardous patients of some health policy literatures, but many are afraid to speak publicly about their medications for fear of disclosing their diagnoses and of damaging relationships and careers. I am sure there are people taking antidepressants for the wrong reasons, and perhaps the antidepressant wars will encourage them to re-evaluate. The debate must make room for the rest of us, though—the ones for whom effectiveness and ineffectiveness have been the research questions of our lives.
View More News Items